First patient receives retinal implant in pivotal trial - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    First patient receives retinal implant in pivotal trial

    Article obtained from Optics.org RSS Feed.

    Pixium Vision says that study on an anticipated 38 patients represents final clinical step before seeking market approval.

    READ MORE
    Apr, 07 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.